Results 231 to 240 of about 257,826 (338)

Exploring 2D Graphene‐Based Nanomaterials for Biomedical Applications: A Theoretical Modeling Perspective

Small Science, EarlyView.
Two‐dimensional graphene‐based nanomaterials are of significant interest in biomedical applications due to their unique physicochemical properties. Computational modeling provides useful insights into their structure and interactions with biological systems, aiding the nanoparticle design.
Alexa Kamboukos, Nevena Todorova, Irene Yarovsky   +2 more
wiley   +1 more source

Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC 409962) and cyclophosphamide therapy of drug-resistant metastatic breast carcinoma [PDF]

, 1977
Cary A. Presant, Albert Van Amburg, Carol Klahr   +2 more
openalex   +1 more source

Nanomedicine Approaches for Autophagy Modulation in Cancer Therapy

Small Science, EarlyView.
Autophagy modulation holds promise for enhancing cancer treatment, yet clinical translation remains challenging. This review explores nanomedicine‐based strategies to improve autophagy‐targeting drugs, highlighting their synergy with chemotherapy, immunotherapy, phototherapy, and gene therapy. It also discusses nanoparticle design and clinical progress,
Sohaib Mahri, Rodolfo Villa, Ya‐Ping Shiau, Menghuan Tang, Kelsey Jane Racacho, Qiufang Zong, Saiful Islam Chowdhury, Tan Hua, Felipe Godinez, Andrew Birkeland, Tzu‐Yin Lin, Yuanpei Li   +11 more
wiley   +1 more source

Effect of high-dose melphalan on marrow and intestinal epithelium in mice pretreated with cyclophosphamide

, 1978
Jeremy Millar, B N Hudspith, T J McElwain, T.A. Phelps   +3 more
openalex   +2 more sources

Adriamycin, BCNU plus cyclophosphamide (ABC) in advanced carcinoma of the head and neck [PDF]

, 1979
Cary A. Presant, Gary Ratkin, Carol Klahr, Carol Brown   +3 more
openalex   +1 more source

Therapy-related second malignant neoplasms on top of neuroblastoma: frequency, types and risk factors. [PDF]

Discov Oncol
Fawzy M, Abdelfattah N, Alaa M, Mohsen I, Soliman S, Salem S, Zekri W, Arafah O.   +7 more
europepmc   +1 more source

Interventional oncology in children: Where are we now?

Journal of Medical Imaging and Radiation Oncology, EarlyView.
Abstract Paediatric Interventional Oncology (IO) lags behind adult IO due to a scarcity of specific outcome data. The suboptimal way to evolve this field is relying heavily on adult experiences. The distinct tumour types prevalent in children, such as extracranial germ cell tumours, sarcomas, and neuroblastoma, differ strongly from those found in ...
Premal Amrishkumar Patel, Fernando Gómez Muñoz   +1 more
wiley   +1 more source

Treatment burden in glomerular diseases: advances and challenges in immunosuppressive therapy. [PDF]

Front Nephrol
Shankar M, Lamech TM.
europepmc   +1 more source

Imaging of Abdominal Complications in Children With Acute Lymphoblastic Leukaemia

Journal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT Acute lymphoblastic leukaemia (ALL) is the most common paediatric malignancy and remains one of the most common causes of cancer‐related death in children and adolescents. Five‐year overall survival rates now exceed 90% with current multidrug chemotherapeutic regimens. This improvement, coupled with the toxicity of chemotherapy, has led to the
Luke R. Holmes, Rishi S. Kotecha, Derek J. Roebuck   +2 more
wiley   +1 more source

Pharmacokinetics of post-transplant cyclophosphamide and its associations with clinical outcomes in pediatric haploidentical hematopoietic stem cell transplantation. [PDF]

Biomark Res
Hong KT, Bae S, Sunwoo Y, Lee J, Park HJ, Kim BK, Choi JY, Cho JY, Yu KS, Oh J, Kang HJ.   +10 more
europepmc   +1 more source